𝛼SK or Search

ENTITY

FibroBiologics (FBLG US)

15

Analysis

Health Care • United States

FibroBiologics, Inc. operates as an early stage, cell therapy company. The Company develops food and drug administration trials related to fibroblast treatments for degenerative disc disease, multiple sclerosis, cancer, wound healing, and other diseases. FibroBiologics serves clients in the United States.

more

Refresh

Exchange Announcement • 09 Oct 2026 05:15

Current Report (Form 8-K | Period ending 2026-10-07)

Exchange Announcement • 19 Sep 2026 04:05

Current Report (Form 8-K | Period ending 2026-09-17)

Exchange Announcement • 15 Sep 2026 19:15

Current Report (Form 8-K | Period ending 2026-09-15)

Exchange Announcement • 24 Aug 2026 20:48

Current Report (Form 8-K | Period ending 2026-08-20)

Exchange Announcement • 01 Aug 2026 04:04

Quarterly Report (Form 10-Q | Period ending 2026-06-30)

Copyright © 2022 Smartkarma Innovations Pte Ltd. All Rights Reserved. v3.70.5

x